摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tripropylene glycol-di-p-tosylate | 175082-11-8

中文名称
——
中文别名
——
英文名称
tripropylene glycol-di-p-tosylate
英文别名
2-[2-[2-(4-Methylphenyl)sulfonyloxypropoxy]propoxy]propyl 4-methylbenzenesulfonate
tripropylene glycol-di-p-tosylate化学式
CAS
175082-11-8
化学式
C23H32O8S2
mdl
——
分子量
500.634
InChiKey
QYEWWDZRUSDZPS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    620.4±55.0 °C(Predicted)
  • 密度:
    1.225±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    33
  • 可旋转键数:
    13
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    122
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    2-二甲氨基吡啶三丙二醇对甲苯磺酰氯三乙胺 作用下, 以 二氯甲烷甲苯 为溶剂, 以19.2%的产率得到tripropylene glycol-di-p-tosylate
    参考文献:
    名称:
    Compositions of iodophenoxy alkylene ethers and pharmaceutically
    摘要:
    本发明揭示了用于口服或逆行检查消化道的X射线造影剂,包括碘苯氧烷醚和药用可接受的粘土在药用可接受的载体中的组合物;以及它们在消化道诊断放射学中的使用方法。
    公开号:
    US05492687A1
点击查看最新优质反应信息

文献信息

  • Compositions of iodophenoxy alkylene ethers in film-forming materials
    申请人:Sterling Winthrop Inc.
    公开号:US05310538A1
    公开(公告)日:1994-05-10
    ##STR1## wherein Z=H, halo, C.sub.1 -C.sub.20 alkyl, cycloalkyl, lower alkoxy, alkoxycarbonyl, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R=C.sub.1 -C.sub.25 alkyl, cycloalkyl, ##STR2## or halo-lower-alkyl, each of which may be optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy, (CR.sub.1 R.sub.2).sub.p --(CR.sub.3 =CR.sub.4).sub.m Q ,or (CR.sub.1 R.sub.2).sub.p --C.tbd.C--Q; R.sub.1, R.sub.2 and R.sub.3 and R.sub.4 are independently H, or lower-alkyl, optionally substituted with halo; x is 1-4; n is 1-4; m is 1-15; p is 1-20; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl These compounds are combined in a polymer for use as an X-ray contrast agent.
    其中 Z=H,卤素,C.sub.1 -C.sub.20 烷基,环烷基,低烷氧基,烷氧羰基,基,其中烷基和环烷基基团可被卤素或卤素-低烷基基团取代;R=C.sub.1 -C.sub.25 烷基,环烷基,或卤素-低烷基,每个基团均可选择地被卤素,-低烷基,芳基,低烷氧基,羟基,羧基,低烷氧羰基或低烷氧羰氧基取代,(CR.sub.1 R.sub.2).sub.p --(CR.sub.3 =CR.sub.4).sub.m Q,或 (CR.sub.1 R.sub.2).sub.p --C.tbd.C--Q;R.sub.1,R.sub.2,R.sub.3 和 R.sub.4 独立地为 H,或低烷基,可选择地被卤素取代;x 为 1-4;n 为 1-4;m 为 1-15;p 为 1-20;Q 为 H,低烷基,低烯基,低炔基,低烷基烯,芳基,或芳基-低烷基。这些化合物被组合在聚合物中用作X射线造影剂。
  • Compositions of iodophenoxy alkylene ethers and cellulose derivatives
    申请人:Sterling Winthrop Inc.
    公开号:US05466435A1
    公开(公告)日:1995-11-14
    Disclosed are contrast agents of the formula ##STR1## wherein Z is H, halo, C.sub.1 -C.sub.20 alkyl, cycloalkyl, lower alkoxy, alkoxycarbonyl, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R is C.sub.1 -C.sub.25 alkyl, cycloalkyl, ##STR2## or halo-lower-alkyl; each of which may be optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy; (CR.sub.1 R.sub.2).sub.p --(CR.sub.3 .dbd.CR.sub.4).sub.m Q, or (CR.sub.1 R.sub.2).sub.p --C.tbd.C--Q; R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are independently H or lower-alkyl, optionally substituted with halo; x is 1-4; n is 1-4; m is 1-15; p is 1-20; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl; in an aqueous, pharmaceutically acceptable carrier comprising a cellulose derivative.
    揭示了以下公式的对比剂##STR1## 其中Z为H、卤素、C.sub.1 -C.sub.20烷基、环烷基、较低的烷氧基、烷氧羰基、基,其中烷基和环烷基基团可以被卤素或卤素-较低烷基基团取代;R为C.sub.1 -C.sub.25烷基、环烷基、##STR2## 或卤素-较低烷基;每个都可以选择性地被卤素、-较低烷基、芳基、较低烷氧基、羟基、羧基、较低烷氧基羰基或较低烷氧基-羰氧基取代;(CR.sub.1 R.sub.2).sub.p --(CR.sub.3 .dbd.CR.sub.4).sub.m Q,或(CR.sub.1 R.sub.2).sub.p --C.tbd.C--Q;R.sub.1、R.sub.2、R.sub.3和R.sub.4独立地为H或较低烷基,可以选择性地被卤素取代;x为1-4;n为1-4;m为1-15;p为1-20;Q为H、较低烷基、较低烯烃基、较低炔烃基、较低烷基烯、芳基或芳基-较低烷基;在含有纤维素生物性、药学上可接受的载体中。
  • Coating varnish composition and antifouling coating composition
    申请人:HITACHI CHEMICAL CO., LTD.
    公开号:EP0608132A1
    公开(公告)日:1994-07-27
    The invention provides a coating varnish composition comprising (A) a polymer obtained by polymerizing (a) at least one unsaturated acid anhydride and (b) at least one other unsaturated monomer, and (B) at least one additive selected from triazole derivatives, benzothiazole derivatives, thiadiazole derivatives, polyethers and carboxylic acid anhydride derivatives and an antifouling coating composition comprising said coating varnish and an antifouling agent containing a coppercompound as major component. Using such compositions the risks of poisoning associated with organotin copolymers are avoided and there are obtained coatings of a coating consuming property and antifouling performance comparable with those of the organotin copolymers which do not gel even when mixed with a copper compound.
    本发明提供了一种涂料清漆组合物,该组合物包含(A)通过聚合(a)至少一种不饱和酸酐和(b)至少一种其他不饱和单体而得到的聚合物,和(B)至少一种选自三唑衍生物苯并噻唑生物噻二唑生物、聚醚和羧酸酐生物的添加剂,以及一种防污涂料组合物,该组合物包含上述涂料清漆和一种以化合物为主要成分的防污剂。使用这种组合物可以避免与有机锡共聚物有关的中毒风险,并获得涂层消耗特性和防污性能与有机锡共聚物相当的涂层,即使与化合物混合也不会凝胶。
  • Compositions of iodophenoxy alkylene ethers in film-formin materials for visualization of the gastrointestinal tract
    申请人:NYCOMED IMAGING AS
    公开号:EP0614670A2
    公开(公告)日:1994-09-14
    Disclosed are x-ray contrast compositions for oral or retrograde examination of the GI tract comprising a polymeric material capable of forming a coating on the GI tract, said polymeric material having atoms containing polarizable electrons thereon, in combination with a divalent cation: and an x-ray contrast producing agent of the formula wherein Z = H, halo, C1-C20 alkyl, cycloalkyl, lower alkoxy, alkoxycarbonyl, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R = C1-C25 alkyl, cycloalkyl, or halo-lower-alkyl, optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy, Ri, R2, R3 and R4 are independently H, lower-alkyl, optionally substituted with halo; x is 1-4; n is 1-5; m is 1-15; p is 1-20; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl; in a pharmaceutically acceptable carrier and a method of its use in diagnostic radiology of the GI tract.
    本发明公开了用于消化道口腔或逆行检查的 X 射线造影剂组合物,该组合物包含一种可在消化道上形成涂层的聚合材料,所述聚合材料上有含有可极化电子的原子,该聚合材料与二价阳离子结合:以及一种X射线造影剂,其式为 其中 Z = H、卤素、C1-C20 烷基、环烷基、低级烷氧基、烷氧羰基、基,其中烷基和环烷基可被卤素或卤代低级烷基取代; R = C1-C25 烷基、环烷基或卤代低烷基,可任选被卤、代低烷基、芳基、低烷氧基、羟基、羧基、低烷氧基羰基或低烷氧基羰氧基取代、 Ri、R2、R3 和 R4 独立地为 H、低级烷基,可选择被卤素取代; x 为 1-4; n 为 1-5 m 是 1-15; p 是 1-20;以及 Q 是 H、低级烷基、低级烯基、低级炔基、低级亚烷基、芳基或芳基-低级烷基。
  • Compositions of iodophenoxy alkylene ethers for visualization of the gastrointestinal tract
    申请人:NYCOMED IMAGING AS
    公开号:EP0619121A2
    公开(公告)日:1994-10-12
    Disclosed are contrast agents of the formula or a pharmaceutically acceptable salt thereof, contained in aqueous compositions and methods for their use in diagnostic radiology of the gastrointestinal tract wherein Z = H, halo, C1-C20 alkyl, cycloalkyl, lower alkoxy, alkoxycarbonyl, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R = Cl-C25 alkyl, cycloalkyl, or halo-lower-alkyl, optionally substituted with halo, fluoro-lower-alkyl, aryl, lower-alkoxy, hydroxy, carboxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy, (CR1 R2)ρ-(CR3 = CR4)mQ, or (CR1 R2)p-C=C-Q; Ri, R2, R3 and R4 are independently H, lower-alkyl, optionally substituted with halo; x is 1-4; n is 1-5; m is 1-15; p is 1-20; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl. in an aqueous, pharmaceutically acceptable carrier.
    公开了式 或其药学上可接受的盐,包含在性组合物中,以及将其用于胃肠道放射诊断的方法,其中 Z = H、卤素、C1-C20 烷基、环烷基、低级烷氧基、烷氧羰基、基,其中烷基和环烷基可被卤素或卤代低级烷基取代; R = Cl-C25 烷基、环烷基或卤代低烷基,可任选被卤、代低烷基、芳基、低烷氧基、羟基、羧基、低烷氧基羰基或低烷氧基羰氧基、(CR1 R2)ρ-(CR3 = Ri、R2、R3 和 R4 独立地为 H、低级烷基,可选被卤素取代;x 为 1-4;n 为 1-5;m 为 1-15;p 为 1-20;Q 为 H、低级烷基、低级烯基、低级炔基、低级亚烷基、芳基或芳基-低级烷基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫